JB Chemicals & Pharmaceuticals Limited Appoints New Directors and Managing Director

JB Chemicals & Pharmaceuticals Limited Appoints New Directors and Managing Director

JB Chemicals & Pharmaceuticals Limited Appoints New Directors and Managing Director​

JB Chemicals & Pharmaceuticals Limited announced that shareholders approved the appointment of several directors via postal ballot. The appointments include Mr. Aman Mehta as Managing Director and Mr. Amal Kelshikar, Mr. Hasmukh Patel, and Mr. Sudhir Menon as Non-Executive Non-Independent Directors.

Mr. Aman Mehta was appointed as Managing Director for a period of 3 years, effective January 21, 2026. He is currently the Managing Director of Torrent Pharmaceuticals Limited and holds a Bachelor's degree in Economics from Boston University and an MBA from Columbia University.

Mr. Amal Kelshikar, appointed on March 23, 2026, brings 32 years of experience in strategic planning and has overseen the India business of Torrent Pharmaceuticals Limited since 2022. He holds a BE in Chemical Engineering and a PGDM from the Indian Institute of Management, Ahmedabad.

Mr. Hasmukh Patel, also appointed on March 23, 2026, has over 33 years of experience in the pharmaceutical industry, most recently as Chief Operating Officer at Torrent Pharmaceuticals Limited. He holds a master's degree in pharmacy.

Mr. Sudhir Menon, appointed on March 23, 2026, is a Chartered Accountant and Cost Accountant with 29 years of experience in finance and corporate management, currently serving as Executive Director (Finance) & Chief Financial Officer of Torrent Pharmaceuticals Limited.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top